Endo International plc announces it has received US Food and Drug Administration (FDA) approval of QWO (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women.
Sixty percent (60%) of women surveyed feel it’s their fault they have cellulite and 57% feel judged for their cellulite, according to new Harris Poll survey results released by Endo Aesthetics LLC, an affiliate of Endo International plc.Read More
Soliton Inc will present the results from its pivotal cellulite trial through a virtual video presentation at the American Academy of Dermatology (AAD) 2020 Virtual Meeting, being held June 12-14, 2020 online, according to a news release.Read More
The results from Soliton Inc’s pivotal cellulite trial will be now be presented at the AAD 2020 Annual Meeting, to now be held virtually in the next 6-8 weeks, the company announces in a media release.Read More
Under the terms of the agreement, Sanmina Corporation will manufacture Soliton’s RAP device and replaceable cartridges, Soliton announces.Read More
The US Food and Drug Administration (FDA) has cleared a new indication statement that shows the benefits of the Cellfina System lasts for 5 years, an increase from the previous 3-year indication, Merz announces.Read More
A growing body of evidence suggests that as many as 30% of cryolipolysis patients treated with the CoolSculpting® System from ZELTIQ Aesthetics can also show improvements in skin texture, laxity, and cellulite. In this article, W. Grant Stevens, MD discusses the cryodermastringo phenomenon.Read More
From kneading and massaging to laser therapy and injections, there’s little someone wouldn’t do, or at least try, if it meant getting rid of their cellulite for good. Is Cellulaze the answer?Read More